同步性食管癌与肺癌:联合解剖性切除是否合适?
本研究评估同步性肺癌与食管癌患者行联合切除的安全性和可行性。从3个三级转诊中心1997至2019年前瞻性数据库识别食管切除术患者,将同期行联合解剖性肺切除者按1:3匹配至单纯食管切除术者。结果显示联合切除组总体并发症更少(56% vs 84%;P = .02),吻合口漏和肺部并发症无差异,无术后死亡。
要点
- 同步性局限性肺癌与食管癌虽罕见,不应偏向非手术治疗。
- 联合食管切除与解剖性肺切除的并发症与单纯食管切除无显著差异。
- 联合切除组总体并发症更少(56% vs 84%;P = .02)。
核心结论
- 同步性局限性肺癌与食管癌患者不应被偏向非手术治疗,因为联合切除的并发症与单纯食管切除无显著差异。
研究设计与样本
- 从3个三级转诊中心1997至2019年前瞻性数据库识别食管切除术患者,将同期行联合解剖性肺切除者按1:3匹配至单纯食管切除术者,匹配因素包括年龄、性别、病理分期、新辅助治疗和手术方式。
主要发现
- 4729例食管切除术中,18例因离散肺部病变行联合解剖性肺切除。
- 匹配后49例单纯食管切除术患者与联合切除组统计学相似。
- Ivor Lewis食管切除术和肺叶切除术是最常见的手术方式。
- 联合切除组总体并发症更少(56% vs 84%;P = .02)。
- 吻合口漏(17% vs 18%)和肺部并发症(39% vs 33%)无差异,无术后死亡,中位总生存4.1年 vs 6.5年(P = .10)。
临床怎么用
- 对于高度选择的同步性局限性肺癌与食管癌患者,可考虑同期行食管切除联合解剖性肺切除。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study evaluated the safety and feasibility of combined resection for patients with synchronous pulmonary and esophageal cancer. METHODS: Patients undergoing esophagectomy between 1997 and 2019 were identified from prospectively collected databases at 3 tertiary referral centers, and those with combined anatomic lung resection at the same setting were matched in a 1:3 ratio to esophagectomy-alone patients, based on age, sex, pathologic stage, neoadjuvant therapy, and surgical procedure. Demographic data, perioperative data, and postoperative complications were compared. Statistical analysis included the unpaired t test, Fisher exact, or χ2 test and Gehan-Breslow analysis. RESULTS: Of 4729 esophagectomies, combined anatomic lung resection was performed in 18 patients with discrete pulmonary lesions. Matching yielded 49 patients who underwent esophagectomy only and were statistically similar compared with patients undergoing combined resections. Ivor Lewis esophagectomy and lobectomy were the most frequent procedures. Combined resections did not have a higher overall complication rate than esophagectomy alone; rather, these patients had fewer overall complications (56% vs 84%; P = .02). Specifically, there were no differences in anastomotic leak (17% vs 18%) or pulmonary complications (39% vs 33%) between combined resection and esophagectomy alone. No postoperative mortality were identified, and median overall survival was 4.1 years vs 6.5 years (P = .10). CONCLUSIONS: Patients with synchronous localized lung and esophageal cancer, although rare, should not be biased toward nonsurgical therapy, because the morbidity associated with combined esophagectomy and anatomic lung resection does not differ significantly from esophagectomy alone in this highly selected group of patients.
引用
- Zhao H, Misariu AM, Ramirez-GarciaLuna JL, et al. Synchronous Esophageal and Lung Cancers-Is Combined Anatomic Resection Appropriate? Ann Thorac Surg. 2021. PMID: 33905733. doi:10.1016/j.athoracsur.2021.04.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。